Differential Gene Expression of BRCA1, ERBB2 and TP53 Biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 4, 2016-02 ,pp. : 519-525

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of the TP53 Tumour Suppressor Gene Product and p53 Auto-antibodies in the Ascites of Women with Ovarian Cancer

By Angelopoulou K.   Diamandis E.P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

Frequent TP53 Gene Alterations (Mutation, Allelic Loss, Nuclear Accumulation) in Primary Non-small Cell Lung Cancer

By Shipman R.   Schraml P.   Colombi M.   Raefle G.   Dalquen P.   Ludwig C.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

An Intronic Deletion in TP53 Gene Causes Exon 6 Skipping in Breast Cancer

By Voglino G.   Castello S.   Silengo L.   Stefanuto G.   Friard O.   Ferrara G.   Fessia L.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1479-1483

Elsevier

Access to resources Recommend Favorite

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

By Rahko E.   Blanco G.   Soini Y.   Bloigu R.   Jukkola A.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 447-453

Elsevier

Access to resources Recommend Favorite